EP Patent

EP1183026A2 — Improved pharmaceutical formulations

Assigned to Abbott Laboratories · Expires 2002-03-06 · 24y expired

What this patent protects

Improved pharmaceutical compositions are provided comprising one or more HIV protease inhibiting compounds having improved dissolution properties in a mixture of a fatty acid, ethanol, and water.

USPTO Abstract

Improved pharmaceutical compositions are provided comprising one or more HIV protease inhibiting compounds having improved dissolution properties in a mixture of a fatty acid, ethanol, and water.

Drugs covered by this patent

Patent Metadata

Patent number
EP1183026A2
Jurisdiction
EP
Classification
—
Expires
2002-03-06
Drug substance claim
No
Drug product claim
No
Assignee
Abbott Laboratories
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.